Results 211 to 220 of about 7,175,991 (316)

Telehealth service use in people with cancer compared to people without cancer: analysis of Patient Experience Surveys in Australia. [PDF]

Support Care Cancer
Ng HS, Walsan R, Harrison R, Koczwara B.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Sexual Orientation-Related Discrimination Among LGB+ Medical Students With Disabilities.

JAMA Netw Open
Sheets ZC, Nguyen M, Lopez JKM, Addams A, Moreland CJ, Boatright D, Meeks LM.   +6 more
europepmc   +1 more source

Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. [PDF]

J Clin Med
García-Aranda M, Martín-García D, Gallejones-Eskubi J, Urrechaga E, Ferreiro J, Portugal V, Portillo I, Jiménez-Toscano M, Legarreta MJ, Quintana JM, Redondo M, Aguirre U, REDISSEC/CARESS-CCR Group.   +12 more
europepmc   +1 more source

References

, 1986
openaire   +2 more sources

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Neoadjuvant Chemotherapy for Male Breast Cancer: A Retrospective Cohort Study. [PDF]

Cancer Med
Yang Z, Ni P, Wang Y, Wang R, Wang B, Ren Y, Ge G, Liu F, He J, Zhou C.   +9 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Pangenomics for Agricultural Breeding: Construction Strategies, Evidence Integration, and Translational Constraints. [PDF]

Biology (Basel)
Shi J, Lu Y, Sheng Z, Liu H, Li K, Chong Y, Gao Z, Deng W, Wu D.   +8 more
europepmc   +1 more source